It’s no secret that the pharmaceutical industry continues to undergo wrenching changes, which have had serious ripple effects on commercial operations.
Commercial ops have far more responsibilities and projects than ever, and they must meet these responsibilities with shorter deadlines and diminished resources, especially as budget tightening takes its toll.
As a result, pharma commercial operations must do more with less, while also elevating their stature to become a truly strategic partner for the company as a whole. This may require major changes, including a full transformation of the global commercial ops organization.
There are three levers—operational, organizational and strategic—that pharmaceutical companies can use to transform their commercial operations. In this video, I describe how focusing on these levers will help drive the evolution from cost center to thought leader.
Is your commercial ops organization "pushing" on these levers—or others? Please share your insights.
About the Author
Sanjay Joshi is a Managing Principal on ZS Associates' executive team and he oversees the firm's global offerings in operations, technology and outsourcing. In addition to having deep expertise in the pharmaceutical and healthcare industries, Sanjay's experience spans technology, consumer products and financial services as well. Prior to joining ZS, Sanjay ran a number of global businesses for large public firms.